The Cabinet of Ministers of Ukraine has added the following industrial parks to the Register of Industrial Parks “Horvatskyi Hostynets” (Mykolaiv, Stryi District, Lviv Region), with an area of 32.34 hectares, and “Bessarabsky AgroTech Park” (Artsyz, Odesa Region), with an area of 23 hectares, to the Register of Industrial Parks, the Ministry of Economy and Environment reported.
According to a statement on the ministry’s website, the Mykolaiv City Council is the initiator of the park’s creation in Lviv Oblast. Preliminary estimates indicate that 913 million hryvnias will be invested in the development of “Khorvatsky Gostinets” by the initiator, private investors, and the management company.
The park is expected to create approximately 1,500 new jobs.
Key areas of focus include the production of electric motors, generators, and transformers; non-metallic mineral products; machinery and equipment for the mining and construction industries; construction materials; as well as the development of mechanical engineering and alternative energy.
The city council initiated the creation of the “Bessarabian AgroTech Park” industrial park in Artsyz, where approximately 1,000 jobs are planned to be created. A total of 884 million hryvnias is expected to be raised from the initiator, private investors, and the management company to develop the facility.
The main areas of focus will be food production—specifically, the processing and canning of potatoes, fruits, and vegetables; the production of vegetable oils and animal fats; other sectors of the food industry; and alternative energy.
“Two parks—two sectors that we really need: machine building and agricultural processing. Not raw materials, but finished products,” Deputy Minister of Economy Vitaliy Kondratov is quoted as saying in the announcement.
The Ministry of Economy notes that the management company of the “Bessarabian AgroTech Park” is eligible for government incentives in the form of non-repayable financial assistance of up to 150 million hryvnia for infrastructure development.
Currently, there are 125 industrial parks registered in Ukraine, spread across nearly all regions.
As previously reported, as of the end of 2025, 37 industrial enterprises had been built or were under construction in industrial parks. The total amount of investment attracted to industrial parks exceeds 45 billion hryvnias.
The Verkhovna Rada of Ukraine has approved, in its entirety, a bill to improve the operation of industrial parks (IPs). According to a correspondent for the “Interfax-Ukraine” news agency, 270 deputies voted in favor of the bill, exceeding the required minimum of 226 votes.
“Based on the results of ongoing monitoring of the development of industrial parks, we identified issues, the solutions to which have now been approved by the Rada. Essentially, these are technical issues that arose during the practical implementation of the legislation adopted in 2022. But resolving each of them will contribute to the faster development of this sector and the emergence of new manufacturing facilities,” wrote the bill’s sponsor, Dmytro Kysilevskyi, deputy chairman of the parliamentary committee on economic development.
He noted that the bill, in particular, more clearly delineates the functions of all entities within an industrial park, and grants the initiator of a park’s creation the ability to also act as the managing company without establishing a separate legal entity.
In addition, the concept of an “eco-industrial park” has been introduced, the Cabinet of Ministers has been granted the authority to establish criteria for them, and a new category of land use designation has been introduced: land for industrial parks.
The procedure for increasing and decreasing the area of an industrial park has also been regulated, as have issues regarding the transfer of ownership rights to a land plot within an industrial park from the park’s initiator to another party; opportunities for establishing industrial parks have been expanded: land plots may now be considered adjacent if there are forest buffer strips between them.
Among the issues addressed are improvements to the competitive selection process for management companies and the introduction of the possibility for management companies whose primary activity is the leasing of real estate to obtain loans under the “5-7-9” program.
Temporary restrictions on the acquisition of power capacity for small electricity distribution systems in industrial parks have also been lifted, and provisions regarding state incentives for industrial parks have been improved, in particular through the transfer of international technical assistance from local government bodies to industrial parks.
As of the end of 2025, 37 factories had been built or were under construction in Ukraine’s industrial parks. Throughout 2026, manufacturing enterprises in the parks continued to open.
As previously reported, Bill No. 12117 was adopted in principle on February 11, 2025, with amendments to its provisions, by a vote of 244 members of parliament.
Ukrainian defense technology manufacturer TAF Industries, in partnership with the Danish company Upteko, has signed a memorandum of understanding (MoU) to establish a joint venture (JV) in Denmark, which is expected to produce thousands of drones per month starting in early 2027.
According to a press release, the memorandum was signed during the DALO Industry Days in Herning, Denmark. This collaboration is part of the “Build with Ukraine” initiative.
Under the agreement, the companies are expected to work on scaling up production capacity in the field of FPV drones and strengthening supply chains.
“Today’s agreement is another strategic step that will contribute to further deepening cooperation both between our companies and between Ukraine and Denmark,” TAF Industries CEO Volodymyr Zinovsky is quoted as saying in the press release.
For his part, Upteko founder Benjamin Meinerz added that the companies jointly aim to foster innovation by developing high-performance systems and building an organization capable of adapting to future challenges.
“Establishing a manufacturing facility and a development office outside of Ukraine creates a solid foundation for cooperation in the fields of research, engineering, and manufacturing,” noted the founder of Upteko.
In June, TAF Industries, together with the Polish Defense Group (Polska Grupa Zbrojeniowa), signed a memorandum of understanding regarding the further localization of production in Poland and the expansion of manufacturing capacity.
The Danish technology company Upteko was founded in 2018 and specializes in developing drone solutions for the maritime and industrial sectors. The company collaborates with industrial partners, government agencies, and representatives of the maritime sector.
Ukrainian defense technology manufacturer TAF Industries produces over 30 types of defense products, including FPV drones and reconnaissance UAVs, electronic warfare systems, remote control solutions, and AI-based combat technologies. The company’s monthly production of FPV drones reaches up to 80,000 units.
The pharmaceutical company “JSC Galichpharm” (Lviv) produced 3.934 million packages of finished pharmaceutical products in the second quarter of 2026, worth approximately 981.424 million UAH.
According to the company’s disclosure in the National Securities and Stock Market Commission (NSSMC) disclosure system, the average cost per package of medicines is 213.18 UAH for injectables, 52.11 UAH for infusions, 117.25 UAH for liquids and syrups, and 52.6 UAH for tablets.
Galichpharm’s total revenue for the second quarter of 2026 amounted to 354.394 million UAH. Total exports reached 115.4 million UAH, or 48.3% of total sales.
Currently, the company supplies products to the Ukrainian market and exports them to Kazakhstan, Uzbekistan, Latvia, Australia, and other countries.
As previously reported, “Galichpharm” (Lviv) produced 22.098 million packages of medicines in 2025 and sold finished products worth 1.774 billion UAH. The company then reported a net loss of 1.151 billion UAH, compared to a net profit of 13.705 million UAH in 2024 (-39% compared to 2023).
As previously reported, in May 2025, the Commercial Court of Lviv Oblast opened bankruptcy proceedings against the pharmaceutical manufacturer JSC “Galichpharm” based on claims filed by LLC “Sky-Development” in the amount of 479.262 million UAH. On April 21, 2025, Sky-Development LLC acquired from JSC “Bank Finansy i Kredit” the rights to claims against JSC “Galichpharm” under loan agreements and security agreements.
The investment company “Sky-Development” won an open auction organized by the Deposit Guarantee Fund for Individuals and acquired the claims of the insolvent JSC “Bank ‘Finansy i Kredit’” under ten loan agreements with leading Ukrainian pharmaceutical companies: JSC “Galichpharm” and JSC “Kyivmedpreparat.” According to Sky Development, the total amount of its claims exceeds 3.5 billion UAH.
For their part, “Kyivmedpreparat” and “Galichpharm” stated that the information disseminated by Sky Development Investment Company is “inaccurate, manipulative, and shows signs of a deliberate attempt to discredit the companies’ operations.” In particular, both companies denied having “multi-billion debts” to “Sky Development.” The pharmaceutical companies characterized the statements by “Sky Development” LLC as “an attempt to illegally and artificially create non-existent creditor debt for a possible future hostile takeover of the companies.”
EXPORTS, Galichpharm, MANUFACTURING, MEDICINES, PHARMACEUTICALS
According to Experts.news, global production of humanoid robots has moved from isolated prototypes to the first mass-produced batches; however, the industry remains highly concentrated: Chinese companies accounted for about 85% of shipments in 2025.
According to estimates by the Chinese research center CCID, in 2025, Chinese manufacturers shipped approximately 14,400 humanoid robots, accounting for 84.7% of the global market. Thus, the global total was approximately 17,000 units. Other studies estimate global shipments at approximately 18,000 units.
According to IDC, the number of humanoid robots shipped worldwide in 2025 increased more than sixfold—by approximately 508%. However, statistics from various research organizations differ significantly, as some count only bipedal robots, while others also include wheeled humanoid platforms and general-purpose robots with artificial intelligence.
China remains the only country where humanoid robots are already being produced by the thousands by several manufacturers simultaneously. There are over 140 companies in the country working on humanoid robots, and the number of models available exceeds 330. AGIBOT, Unitree, and UBTECH have become the largest manufacturers.
TrendForce expects Chinese production of humanoid robots to grow by another 94% in 2026. Unitree and AGIBOT are expected to maintain their leading positions thanks to their well-developed supply chains, access to low-cost actuators, batteries, and sensors, and their capacity for mass assembly.
China’s advantage lies not only in artificial intelligence but also in its ability to rapidly reduce the cost of hardware. Some of Unitree’s entry-level models are already priced below $6,000, while most American and European systems are geared toward more expensive industrial pilot projects.
The U.S. lags significantly behind China in terms of the actual number of robots produced, but it has the largest announced manufacturing projects outside of China.
Figure has launched BotQ, a facility whose first production line is designed to produce up to 12,000 humanoid robots per year. In April 2026, the company announced its transition from prototypes to the production phase and that it had reached an assembly rate of one robot per hour.
Agility Robotics operates the RoboFab plant in Oregon with a potential capacity of over 10,000 Digit robots per year. Actual output is currently significantly lower than the stated maximum capacity.
The U.S.-Norwegian company 1X has begun full-scale production of its NEO home robot at a factory in California. Tesla is setting up its first production lines for Optimus but has not yet disclosed confirmed data regarding mass production.
South Korea’s Hyundai Motor Group plans to build a facility in the U.S. with a capacity of up to 30,000 robots per year by 2028. The facility is expected to produce, among other things, the Atlas humanoid robots developed by Boston Dynamics. The first Atlas robots are scheduled to arrive at Hyundai’s U.S. facilities in 2028.
One of the most advanced European projects is Germany’s NEURA Robotics, which has developed the 4NE1 humanoid robot.
The company calls it the first European humanoid robot ready for industrial production. NEURA is collaborating with Bosch and Schaeffler, planning to scale up production of robots for industry, logistics, and service tasks.
In 2026, NEURA announced that it had raised up to $1.4 billion to expand mass production and develop a network of centers where robots will be trained to perform real-world tasks.
In Serbia, AGIBOT and Minth Group are preparing to launch a facility in Šabac. The initial production volume is stated at 1,000–2,000 humanoid robots per year. The facility is expected to open in August 2026, although the timeline has already been revised several times. Therefore, Serbia should for now be classified among countries with announced but not yet confirmed mass production.
If the project is implemented, Serbia could become one of the first countries in Europe where Chinese humanoid robots will be mass-produced and adapted for regional markets.
Japan has many years of experience in developing humanoid robots, but so far has focused primarily on research, components, medicine, and elder care. Kawasaki continues to develop the Kaleido platform but has not announced mass production on a scale comparable to that of Chinese companies. TrendForce believes that Japan’s competitive advantage could lie in actuators, sensors, control systems, and solutions for elderly care.
In South Korea, Samsung has acquired control of Rainbow Robotics and intends to integrate its robotics developments with its own artificial intelligence and software technologies. Hyundai is simultaneously developing Atlas through its subsidiary Boston Dynamics, though the group plans to build a large factory in the U.S.
There is no comprehensive international registry of humanoid robot production. Companies disclose the potential capacity of their factories much more frequently than actual production volumes, and the term “humanoid robot” is applied to various types of devices.
The only reliably confirmed fact is China’s leadership, with a share of approximately 85% of global shipments in 2025. The remaining roughly 15% is accounted for primarily by the U.S. and small batches, prototypes, and pilot series from Europe, Japan, and South Korea.
In 2026–2028, the distribution may change following the launch of plants by Figure, Agility Robotics, Tesla, Hyundai, NEURA, and the Serbian AGIBOT project. However, for now, China retains a significant advantage in terms of actual production volume, component costs, and supply chain readiness.
The “Chervona Zirka” Chemical and Pharmaceutical Plant (Kharkiv) produced goods worth 546.883 M UAH in 2025 and sold goods worth 526.744 M UAH.
According to a report published on the company’s website, the cost of goods sold in 2025 amounted to 213.733 million UAH.
The company reported that 96.4% of its output consisted of pharmaceutical products in the form of tablets, capsules, ointments, and tinctures.
Meanwhile, production of perfumes and cosmetics, which accounted for 2.9% of total sales, amounted to 15.121 million UAH.
“Despite the difficult times our country is facing, the company operated as usual in two shifts, with production capacity utilized at 67%. Currently, the company has increased its production and sales volumes compared to the pre-war period. Sales of finished products were primarily conducted on a credit basis, sometimes with payment terms of up to 60 days or on a prepayment basis. Sales volumes for the reporting year amounted to approximately 44 million UAH per month. “The share of the Ukrainian market is up to 2%; there were no exports in 2025,” the company’s report states.
“Chervona Zirka Chemical and Pharmaceutical Plant is a Ukrainian manufacturer of pharmaceuticals, therapeutic cosmetics, and dietary supplements.
According to data from the OpenDataBot system, the company’s net profit for 2024 was 24.063 million UAH, which is 64% more than in 2023.
The company’s ultimate beneficiary is Olena Galkina.
KHARKIV, MANUFACTURING, MEDICATION, PHARMACEUTICALS, Червона зірка
